Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers-Reference-Cited by-同舟云学术

Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers

Published:2022-11-16 Issue:2 Volume:197 Page:277-285
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Ogony Joshua,Hoskin Tanya L.,Stallings-Mann Melody,Winham Stacey,Brahmbhatt Rushin,Arshad Muhammad Asad,Kannan Nagarajan,Peña Alvaro,Allers Teresa,Brown Alyssa,Sherman Mark E.,Visscher Daniel W.,Knutson Keith L.,Radisky Derek C.,Degnim Amy C.^ORCID

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06786-y.pdf

Reference41 articles.

1. Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812–822

2. Gudmundsdottir K, Ashworth A (2006) The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25(43):5864–5874

3. Venkitaraman AR (2001) Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J Cell Sci 114(Pt 20):3591–3598

4. Strickland KC, Howitt BE, Shukla SA, Rodig S, Ritterhouse LL, Liu JF et al (2016) Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer. Oncotarget 7(12):13587–13598

5. Nolan E, Vaillant F, Branstetter D, Pal B, Giner G, Whitehead L et al (2016) RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. Nat Med 22(8):933–939

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen receptor regulation of the immune microenvironment in breast cancer;The Journal of Steroid Biochemistry and Molecular Biology;2024-06

2. Peripheral immunophenotyping reveals lymphocyte stimulation in healthy women living with hereditary breast and ovarian cancer syndrome;iScience;2024-06

3. The Tumor Immune Microenvironment in Breast Cancer Progression;Acta Oncologica;2024-05-23

4. Non-sclerosing (T-cell) and sclerosing (B-cell) lymphocytic lobulitis in diagnostic breast biopsies: Clinical, imaging, and pathologic features;Human Pathology;2024-04

5. Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities;Critical Reviews in Oncology/Hematology;2023-10